These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
317 related items for PubMed ID: 8361115
1. [Retreatment of pulmonary tuberculosis--duration of chemotherapy]. Wada M, Seita A, Mori T, Ogata H, Sugie T, Sugita H. Kekkaku; 1993 Jul; 68(7):469-78. PubMed ID: 8361115 [Abstract] [Full Text] [Related]
2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H. Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [Abstract] [Full Text] [Related]
3. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature]. Shishido Y, Nagayama N, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Komatsu H, Yotsumoto H. Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045 [Abstract] [Full Text] [Related]
4. [Nine month chemotherapy with INH and rifampicin for non-cavitary pulmonary tuberculosis]. Kino C, Sato M, Iwasaki T, Takase A, Kinoshita T, Yamaguchi T, Kinjo T, Odo A, Hara M, Hirata H. Kekkaku; 1991 Apr; 66(4):291-7. PubMed ID: 2051705 [Abstract] [Full Text] [Related]
5. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study]. Yoshiyama T, Ogata H, Ito K, Aono A, Wada M. Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318 [Abstract] [Full Text] [Related]
10. [Research and control of relapse tuberculosis cases]. Yamagishi F, Toyota M. Kekkaku; 2009 Dec; 84(12):767-8. PubMed ID: 20077861 [Abstract] [Full Text] [Related]
11. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results]. Fujino T, Hasegawa N, Satou R, Komatsu H, Kawada K. Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579 [Abstract] [Full Text] [Related]
12. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases]. Shigetoh E, Murakami I, Yokosaki Y, Kurimoto N. Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128 [Abstract] [Full Text] [Related]
13. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S. East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516 [Abstract] [Full Text] [Related]
14. [Management of INH and RFP-resistant refractory tuberculosis]. Kekkaku; 1991 Oct; 66(10):687-706. PubMed ID: 1960917 [Abstract] [Full Text] [Related]
18. [Chemotherapy of pulmonary Mycobacterium kansasii infection]. Mizutani S. Kekkaku; 1996 Sep; 71(9):527-31. PubMed ID: 8914388 [Abstract] [Full Text] [Related]
19. [Evaluation of the streptomycin twice weekly with INH and RFP for initial therapy of pulmonary tuberculosis]. Toyota E, Suzuki T, Tagawa K, Takahara M, Ito M, Arai T, Kabe J, Baba H. Kekkaku; 1994 Sep; 69(9):559-63. PubMed ID: 7967317 [Abstract] [Full Text] [Related]